| Literature DB >> 20038461 |
Bi-mang Fu1, Xiao-shun He, Si Yu, An-bin Hu, Jie Zhang, Yi Ma, Nga-lei Tam, Jie-fu Huang.
Abstract
Semimature dendritic cells (smDCs) can induce autoimmune tolerance by activation of host antigen-specific CD4(+)CD25(+) regulatory T (Treg) cells. We hypothesized that donor smDCs injected into recipients would induce effector T-cell hyporesponsiveness by activating CD4(+)CD25(+)Treg cells, and promote skin allograft survival. Myeloid smDCs were derived from C57BL/6J mice (donors) in vitro. BALB/c mice (recipients) were injected with smDCs to generate antigen-specific CD4(+)CD25(+)Treg cells in vivo. Allograft survival was prolonged when BALB/c recipients received either C57BL/6J smDCs prior to grafting or C57BL/6J smDC-derived CD4(+)CD25(+)Treg cells post-grafting, and skin flaps from these grafts showed the highest IL-10 production regardless of rapamycin treatments. Our findings confirm that smDCs constitute an independent subgroup of DCs that play a key role for inducing CD4(+)CD25(+)Treg cells to express high IL-10 levels, which induce hyporesponsiveness of effector T cells. Pre-treating recipients with donor smDCs may have potential for transplant tolerance induction. 2009 Elsevier Inc. All rights reserved.Entities:
Mesh:
Substances:
Year: 2009 PMID: 20038461 DOI: 10.1016/j.cellimm.2009.11.003
Source DB: PubMed Journal: Cell Immunol ISSN: 0008-8749 Impact factor: 4.868